Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Advances and treatment strategies for metastatic hormone-sensitive prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK
Advances and treatment strategies for metastatic hormone-sensitive prostate cancer ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )
5 Feb 2021

Outcomes of black and white men with prostate cancer in an equal access healthcare setting

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK
Outcomes of black and white men with prostate cancer in an equal access healthcare setting ( Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK )
5 Feb 2021

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for January 25 - 31, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
4 Feb 2021

The role of a physician assistant in oncology

Noam Shabani - Dana-Farber Cancer Institute, Boston, USA
The role of a physician assistant in oncology ( Noam Shabani - Dana-Farber Cancer Institute, Boston, USA )
3 Feb 2021

Role of PARP inhibitors in treating advanced prostate cancer

Noam Shabani - Dana-Farber Cancer Institute, Boston, USA
Role of PARP inhibitors in treating advanced prostate cancer ( Noam Shabani - Dana-Farber Cancer Institute, Boston, USA )
3 Feb 2021

Escalation and descalation in neoadjuvant time to treatment of TNBC

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Escalation and descalation in neoadjuvant time to treatment of TNBC ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
3 Feb 2021

Highlights from BGICC 2021

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from BGICC 2021 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
3 Feb 2021

WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC

Dr Joshua Bauml and Dr Joshua Sabari
WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC ( Dr Joshua Bauml and Dr Joshua Sabari )
3 Feb 2021

New data from rare EGFR alterations in NSCLC from WCLC 2020

Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong
New data from rare EGFR alterations in NSCLC from WCLC 2020 ( Prof Tony Mok - Chinese University of Hong Kong, Shatin, Hong Kong )
2 Feb 2021

A new way of thinking on the origin of breast cancer and how early breast cancer should be treated

Prof László Tabár - University of Uppsala, Uppsala, Sweden
A new way of thinking on the origin of breast cancer and how early breast cancer should be treated ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021

The history of breast cancer diagnosis

Prof László Tabár - University of Uppsala, Uppsala, Sweden
The history of breast cancer diagnosis ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )
29 Jan 2021

Recent therapies for HER2 advanced breast cancer

Dr Sandra Swain - Georgetown University, Washington DC, USA
Recent therapies for HER2 advanced breast cancer ( Dr Sandra Swain - Georgetown University, Washington DC, USA )
29 Jan 2021